IGFBP3 and breast neoplasm: The clinical significance of these findings was underscored by two independent groups showing that high expression of IGFBP-3 in breast tumor tissue is associated with markers of aggressiveness and poor prognosis, including ER- and progesterone receptor- (PR-) negativity, high S-phase fraction, and aneuploidy [32, 33].